Skip to main content
. 2012 Jul 1;6(4):786–796. doi: 10.1177/193229681200600408

Figure 11.

Figure 11

Mean PK profiles of ultra-rapid analog insulin formulations following SC administration to diabetic miniature swine (dose = 0.25 U/kg). (A) BIOD-200 (n = 10) vs lispro (n = 8), (B) BIOD-300 (n = 4) vs aspart (n = 4), and (C) BIOD-400 (n = 5) vs glulisine (n = 11).